Chris Abell
Chris Abell | |
|---|---|
Abell in 2016 | |
| Born | Christopher Abell 11 November 1957 |
| Died | 26 October 2020 (aged 62) |
| Nationality | British |
| Education | University of Cambridge (BA, MA, PhD) |
| Known for | Astex biosynthesis as targets for the rational design of antimicrobials; fragment-based approaches to enzyme inhibition; and biological nanotechnology |
| Awards | Hickinbottom Award (1991) |
| Scientific career | |
| Fields | Biological chemistry |
| Institutions | University of Cambridge Brown University |
| Thesis | Polyketide biosynthesis (1982) |
| Doctoral advisor | James Staunton |
| Doctoral students | Shankar Balasubramanian Alessio Ciulli |
| Website | www |
Christopher Abell (11 November 1957 – 26 October 2020) was a British biological chemist who was a professor of biological chemistry at the Yusuf Hamied Department of Chemistry and Todd-Hamied Fellow of Christ's College, Cambridge. On his 2016 election to the Royal Society, Abell's research was described as having "changed the face of drug discovery."